Study identifies PTX-3 as potential marker for long COVID and tissue damage

A research team working at MedUni Vienna has demonstrated that a specific component of the immune system (PTX-3) remains at significantly higher levels in the blood of patients who have suffered from severe COVID-19, even months…

Continue Reading